Vaccines List

Actemra (Tocilizumab) is an Interleukin-6 (IL-6) rheumatoid arthritis that could help to save the lives of one in 12 intensive care patients with severe Covid.Read more...

Ad5-EBOV is an adenovirus type 5 vector-based Ebola virus disease vaccine that protects against Ebola virus disease.Read more...

Adacel vaccine contains noninfectious tetanus, diphtheria, and pertussis proteins, aluminum phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde. Read more...

Afluria Quadrivalent is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B.Read more...

Ambirix contains inactivated (killed) hepatitis A virus and ‘surface antigen’ (proteins from the surface) parts of the hepatitis B virus as active substances.Read more...

ASP3772 utilizes the Multiple Antigen Presenting System (MAPS) platform which uniquely presents key epitopes of the desired antigens (polysaccharides and/or proteins) to induce a robust and broad immune response against challenging diseases.Read more...

ATX-GD-59 is a candidate for potential treatment to target the immunological basis of Graves' disease.Read more...

Avigan (favipiravir) is an antiviral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses.Read more...

Bacille Calmette-Guerin (BCG) vaccine is an attenuated, live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis.Read more...

Baricitinib is a janus kinase inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation.Read more...

Bexsero contains different proteins taken from group B Neisseria meningitidis bacteria. The combination of proteins was chosen to protect against the majority of MenB strains. They are also expected to protect against other types of meningococcal bacteria, including MenW.Read more...

BioThrax, Anthrax Vaccine Adsorbed, is made from cell-free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis.Read more...

BPZE1 is an intranasal vaccine candidate that consists of a live, attenuated form of the pertussis bacterium.Read more...

Brilife is a recombinant vesicular stomatitis virus (VSV), an animal virus that does not cause disease in humans, and where the spike protein was replaced with that of SARS-CoV-2Read more...

Cecolin HPV Vaccine protects women against HPV 16 and 18, two major HPV types causing 70 percent of all cervical cancers, the third most common cancer among women.Read more...

ChAdOx1 MERS is a vaccine candidate to treat MERS coronavirus.Read more...

Chirorab is an inactivated rabies virus of the strain Flury LEP.Read more...

Convidicea (Ad5-nCoV) is a genetically engineered vaccine candidate with the replication-defective adenovirus type 5 as the vector to express SARS-CoV-2 spike protein.Read more...

CoronaVac COVID-19 vaccine is based on an inactivated pathogen.Read more...

CoVepiT is a prophylactic vaccine candidate against COVID-19 based on optimized peptides selected to induce a lasting sentinel T lymphocyte immune response against SARS-CoV-2 in barrier tissues such as the respiratory tract and the lung.Read more...

Regeneron COVID-19 Antibody Cocktail (REGN-COV2) is a combination of casirivimab and imdevimab antibodies which was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19.Read more...

CoVLP SARS-CoV-2 vaccine uses living plants as bioreactors to produce non-infectious versions of viruses Read more...

CTH522 is a Chlamydia vaccine candidate adjuvanted with CAF01 liposomes or aluminium hydroxide.Read more...

CVnCoV is an mRNA vaccine candidate that utilizes nucleotides without chemical modifications in the mRNA.Read more...

Delta gD-2 (∆gD-2) Herpes Vaccine candidate elicits antibodies that facilitate the killing of infected cells, which then rapidly clears the HSV-1 and HSV-2 viruses.Read more...

Dexamethasone is a corticosteroid that reduces inflammation in a range of conditions, including inflammatory disorders and certain cancers. Read more...

Ebanga (mAb114) is a human IgG1 MAb targeted to the Zaire ebolavirus glycoprotein (GP).  Ebanga is a single monoclonal antibody that binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cells.Read more...

Encepur is a vaccine that consists of an inactivated and purified Tick-Borne Encephalitis (TBE) virus/strainRead more...

The EpiVacCorona vaccine contains fragments extracted from the virus synthetic peptide antigens. Read more...

Eupolio Polio Vaccine is a Sabin-Inactivated Polio Vaccine (Sabin-IPV).Read more...

Flu-v is a synthetic universal flu vaccine candidate offering long-lasting protection across a broad spectrum of influenza.Read more...

Fluad is a quadrivalent inactivated flu vaccine with an adjuvant designed specifically for people 65 years and older.Read more...

Flublok Quadrivalent is a recombinant influenza vaccine. Read more...

Flulaval Quadrivalent is a quadrivalent, split-virion, inactivated influenza virus vaccine prepared from virus propagated in the allantoic cavity of embryonated hens’ eggs.Read more...

Fluzone Quadrivalent and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Gardasil 9 consists of HPV proteins, Types 6, 11, 16, 18, 31, 33, 45, 52, and 58, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, Polysorbate 80, sodium borate, and water for injection.Read more...

GEN-003 is an experimental immunotherapy vaccine comprised of 2 HSV-2 proteins, glycoprotein D2 and ICP4.2, and Matrix-M2 adjuvant (M2).Read more...

GEO-CM01 vaccine candidate is based upon a novel platform that integrates our recombinant Modified Vaccinia Ankara (MVA) vector technology with advanced antigen design and state-of-the-art manufacturing technologies.Read more...

GI.1/GII.4 is a tablet oral norovirus vaccine consisting of both Monovalent GII.4 VXA-G2.4-NS and Monovalent GI.1 VXA-G1.1-NN.  Read more...

GOVX-B11 is a vaccine candidate that uses recombinant DNA and recombinant modified vaccinia Ankara (MVA) vaccines to express non-infectious virus-like particles. Read more...

HB-201 Monotherapy to treat HPV16+ cancers is based on HOOKIPA's proprietary arenavirus platform.Read more...

Hecolin is a recombinant vaccine which contains the hepatitis E virus (HEV)-like particles prepared using a recombinant Escherichia coli expression systemRead more...

Heplisav-B combines hepatitis B surface antigen with Dynavax's proprietary Toll-like Receptor (TLR), 9 agonist, to enhance the immune response.Read more...

Herpes simplex virus (HSV) vaccine development has been an ongoing challenge for decades.Read more...

HSV529 is a herpes vaccine candidate that is classified as a replication-defective virus, where the virus possesses all the components of the wild-type HSV virus with the exception of two proteins UL5 and UL29 that are involved in viral DNA replication.Read more...

ImmuneFx is a therapeutic vaccine candidate which expresses a bacterial antigen on the surface of a patient’s own tumor cells. IFx primes and educates the immune system to destroy tumor cells throughout the body without harming healthy cells and tissues.Read more...

Infanrix is a vaccine indicated for immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks.Read more...

INO-3107 is a DNA medicine being evaluated for the treatment of recurrent respiratory papillomatosis.Read more...

INO-470 is a DNA plasmid vaccine that expresses the MERS CoV spike (S) glycoprotein.Read more...

INO-A002 is a DNA-encoded monoclonal antibody (dMAb™) technology candidate.Read more...

IVX-121 an RSV vaccine candidate incorporates a stabilized prefusion F antigen licensed from NIAID/NIHRead more...

Janssen COVID-19 vaccine candidate (Ad26.COV2-S) is an adenovirus serotype 26 (Ad26) vector-based vaccine that elicits a robust immune response as demonstrated by neutralizing antibodiesRead more...

JYNNEOS smallpox vaccine is based on a live, attenuated vaccinia virus (Modified Vaccinia Ankara, MVA-BN), incapable of replicating in the body, yet still capable of eliciting a potent immune response.Read more...

Vyrologix (Leronlimab, PRO 140) is a drug candidate that is a CCR5 antagonist with the potential for multiple therapeutic indications including COVID-19Read more...

M-001 vaccine is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...

M72/AS01E is a subunit vaccine candidate comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the GlaxoSmithKline proprietary adjuvant AS01E.Read more...

Menactra contains N meningitidis serogroup 8 A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid 9 protein. N meningitidis A, C, Y, and W-135 strains are cultured on Mueller Hinton agar and 10 grown in Watson Scherp media containing casamino acid.Read more...

Metablok is a novel peptide drug candidate for treating inflammation in the lungs, liver, and kidneys. Read more...

Moderna COVID-19 (mRNA-1273) is an mRNA vaccine candidate targeting the novel coronavirus SARS-CoV-2 encoding for a prefusion stabilized form of the Spike (S) protein.Read more...

Mosquirix (RTS,S/AS01) is a recombinant vaccine candidate consisting of the P. falciparum circumsporozoite protein (CSP) from the pre-erythrocytic stage.Read more...

mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...

mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.Read more...

MV-CHIK is a vaccine candidate utilizing Themis’ measles vector platform. MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins.Read more...

MVA-MERS-S (Modified Vaccinia virus Ankara) is a vaccine candidate that contains the full-length spike gene of MERS-CoV.Read more...

MVA-BN-RSV vaccine incorporates five different RSV antigens to stimulate a broad immune response against both RSV subtypes (A and B), thus mimicking the immune response observed following a natural response to an RSV infection.Read more...

MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune responseRead more...

NanoVax is an adjuvant platform used in the development of a vaccine candidate that will provide protection against the two viruses that can cause genital herpes. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.Read more...

NEO-PV-01  Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...

Sinopharm New Crown COVID-19 is an inactivated vaccine that is made of virus particles that are grown in culture and lack disease-producing capability.Read more...

Nimenrix is indicated for the active immunization of individuals from 6 weeks to 55 years of age against invasive meningococcal diseases caused by Neisseria meningitidis serogroups A, C, W-135 and Y.Read more...

nOPV2 Polio Vaccine candidate is derived from the live, infectious virus — but this time it has been ‘triple-locked’ using genetic engineering, to prevent it from becoming harmfulRead more...

NVX-CoV2372 is a stable, prefusion protein COVID-19 coronavirus vaccine candidate made using Novavax’s proprietary nanoparticle technology.Read more...

Orimune is a liquid oral poliovirus vaccine (OPV) that is taken by mouth to help prevent polio infection. Orimune contains live attenuated Sabin strain types 1,2, and 3.Read more...

Pamvac is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).Read more...

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.Read more...

Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...

PF-06482077 (20vPnC) is a 20-Valent pneumococcal conjugate vaccine candidate to help protect adults 18 years and older from a substantial invasive pneumococcal disease and pneumonia burdenRead more...

PIpepTolDC is an investigational vaccine that uses a person’s own immune cells, a beta cell protein and vitamin D3 to potentially treat type 1 diabetesRead more...

Plaquenil (hydroxychloroquine) is used to prevent or treat malaria, and for certain rheumatoid arthritis, systemic lupus erythematosus, and porphyria cutanea trade therapies.Read more...

Pneumosil is indicated against invasive disease, pneumonia, and acute otitis media caused by 10 Streptococcus pneumoniae serotypes in infants and toddlers from 6 weeks up to 2 years of age.Read more...

PolyPEPI1018 an investigational off-the-shelf vaccine for colorectal cancerRead more...

Priorix is a vaccine to protect against measles, mumps, and rubella. Priorix is currently licensed outside the USA in over 100 countries.Read more...

ProscaVax vaccine incorporates scientifically proven and clinically validated treatments for cancer.Read more...

PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.Read more...

Quadracel vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...

RabAvert is a vaccine that contains an inactivated rabies antigen.Read more...

Redeeflu is a nasal vaccine candidate utilizing a proprietary M2 deleted, single replication (M2SR) influenza virus.Read more...

ResVax is a vaccine candidate composed of recombinant RSV F nanoparticles adsorbed to aluminum phosphate. The F protein is essential to RSV infectivity and is the target of palivizumab.Read more...

RiVax Ricin Toxin Vaccine is Soligenix's proprietary heat stable recombinant subunit vaccine developed to protect against exposure to ricin toxin.Read more...

Rotarix is a live, attenuated rotavirus vaccine derived from the human 89-12 strain which belongs to G1P[8] typeRead more...

The development of Respiratory Syncytial Virus (RSV) vaccines has been identified as a priority for the WHO Initiative for Vaccine Research.Read more...

RV144 is an HIV vaccine candidate that combines two different vaccine types: a prime and a booster.Read more...

The Sanofi - GSK vaccine candidate combines innovative technologies to produce an adjuvanted recombinant protein-based COVID-19 vaccine.Read more...

Sci-B-Vac is a licensed, third-generation hepatitis B  trivalent vaccine which mimics all three surface antigens, pre-S1, pre-S2, and S, of the hepatitis B virus (“HBV”).Read more...

scMAYV-E is a novel DNA vaccine that encodes a synthetically-designed consensus MAYV envelope sequence.Read more...

Shingrix is an adjuvanted recombinant zoster vaccine, consisting of the varicella-zoster virus glycoprotein E antigen and the AS01B adjuvant system, and a proprietary adjuvant containing QS-21 and MPL with liposomes.Read more...

Sinovac's PPV23 Pneumococcal Vaccine consists of 23 pneumococcal serotypes that are most frequently found in China.Read more...

SpFN SARS-CoV-2 vaccine attaches a certain type of spike protein to the polymerized version of ferritin to prevent COVID-19 diseaseRead more...

Stamaril is a live, attenuated vaccine that contains the active substance Yellow fever virus 17D-204 strain produced in specified pathogen-free chick embryos.Read more...

TAK-003 is a live attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus. Read more...

TAK-426 (PIZV) is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.Read more...

TG4001 is a therapeutic cancer vaccine candidate using an attenuated and modified poxvirus as a vector expressing the HPV16 E6 and E7 proteins and interleukin-2. Read more...

UK marketing authorization was granted for Sanofi Pasteur’s Trivalent Influenza Vaccine High Dose. TIV High Dose is approved for the prevention of influenza in people 65 years of age and older,1 a population that is particularly vulnerable to influenza infection and its complications2Read more...

TMCP2 is a vaccine candidate to treat Gonorrhea. It is a complex peptide that is both scalable and economically produced to a high degree of purity.Read more...

Trumenba is a sterile suspension composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).Read more...

TY014 will be the first therapeutic vaccine specifically targeting the Yellow Fever Virus to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered to infected cases to reduce disease severity within the patient and their contacts.Read more...

Typhim VI is a sterile solution, prepared from the purified polysaccharide capsule of Salmonella typhi (Ty 2 strain).Read more...

The COVAXX vaccine is designed to target a critical antigen from the S protein (Receptor Binding Domain, RBD) thought to be necessary for viral attachment to human cells plus additional viral epitopes (from other viral structural proteins) designed to promote B-cell and CD8+ T-cell memory responses. Read more...

UV1 is a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase.Read more...

V180 is inactivated, containing only the truncated form of the structural envelope protein, which prevents serotypes from interfering with each other.Read more...

Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...

Vaxart VXA-CoV2-1 is an oral tablet vaccine targeting the novel SARS-CoV-2 coronavirus.Read more...

Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...

VBI-1901 is a cancer vaccine that VBI Vaccines has designed to treat glioblastoma multiforme and medulloblastoma, two types of brain tumors.Read more...

VCL-HB01 is a therapeutic HSV plasmid DNA vaccine candidate formulated with Vaxfectin.Read more...

VGX-3100 is an investigational immunotherapy vaccine that includes DNA plasmids targeting the E6 and E7 proteins of HPV types 16 and 18.Read more...

VIR-2703 is an investigational RNAi therapeutic which will be developed for targeting the SARS-CoV-2 genome for the treatment of Covid-19 (novel coronavirus).Read more...

Vitagerpavac is the only multivalent vaccine in the world for the treatment of chronic herpesvirus infection (HCV) of types I and IIRead more...

VLA15 is a multivalent Lyme Disease vaccine candidate targeting the outer surface protein A (OspA) of Borrelia. It is designed for prophylactic, active immunization against Lyme disease aiming for protection against the majority of human pathogenic Borrelia species.Read more...

VLA1601 is a purified, inactivated, whole Zika virus (ZIKV) vaccine candidate adsorbed on aluminum hydroxide (alum).Read more...

VPM1002  is a genetically modified BCG vaccine derived from the Mycobacterium bovis BCG subtype Prague characterized as rBCGÄureC::Hly+. Read more...

VRC5283 is a Zika Virus DNA Vaccine candidate.  It is composed of a single closed-circular DNA plasmid that encodes with wild type precursor transmembrane M and envelope proteins from the H/PF/2013 strain of ZIKV.Read more...

VXN-319 is a semi-synthetic conjugate early-stage vaccine candidate. Read more...

YF-VAX is prepared by culturing the 17D-204 strain of yellow fever virus in living avian leukosis virus-free chicken embryos. The vaccine contains sorbitol and gelatin as a stabilizer, is lyophilized, and is hermetically sealed under nitrogen.Read more...

Zostavax is a live, attenuated varicella-zoster virus vaccine.Read more...